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SHORT REPORT
B-type natriuretic peptide in reversible myocardial
ischaemia
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Background: Coronary heart disease is associated with
increased B-type natriuretic peptides (BNPs), and, although
controversial, may cause exaggerated exercise-induced BNP
secretion. We investigated BNP in relation to reversible
myocardial ischaemia.
Materials and methods: Serum N-terminal proBNP (NT-
proBNP) was measured before and after an exercise
electrocardiogram test (ETT) in 14 patients with and 45
patients without exercise-induced myocardial ischaemia.
Statistical analysis was carried out on logarithmically
transformed data. Results, however, are pre-transformed
data.
Results: NT-proBNP increased with exercise both in ETT-
positive patients (mean (SD) 71.4 (41.2) v 76.8 (44.0) ng/l;
p,0.001) and ETT-negative patients (54.0 (61.2) v 60.1
(69.0) ng/l; p,0.001). Pre-exercise and post-exercise NT-
proBNP were higher (p,0.05) in ETT-positive than in ETT-
negative patients. Incremental NT-proBNP was similar in ETT-
positive (4.7 (4.2) ng/l) and ETT-negative (6.2 (8.6) ng/l)
patients.
Conclusion: Serum NT-proBNP concentrations are higher in
patients with exercise-induced myocardial ischaemia than in
those without. Exercise-induced electrocardiographic myo-
cardial ischaemia, however, is not associated with exagger-
ated BNP secretion.
B
-type natriuretic peptide (BNP) and N-terminal proBNP
fragment (NT-proBNP) are increased in coronary heart
disease (CHD), and the increase in these peptides may
be directly related to the severity of CHD.1–4 It has been
suggested that patients with CHD have exaggerated BNP or
NT-proBNP secretion during transient myocardial ischae-
mia,4–10 but this is controversial.1 11–12
The exercise electrocardiographic tolerance test (ETT)
remains a cornerstone in the diagnosis of CHD, as it is
commonly available and cost effective. There are, however,
few data on BNP and NT-proBNP in relation to the ETT. If,
however, proved to be of value, NT-proBNP might be useful
in the assessment and management of patients with CHD.
We, therefore, measured serum NT-proBNP before and
after an ETT to investigate whether increased exercise-
induced NT-proBNP secretion is a feature of symptomatic
exercise-induced electrocardiographic myocardial ischaemia.
MATERIAL AND METHODS
Patients
Patients undergoing an ETT were recruited from a rapid access
chest pain clinic. All patients presented with chest pain.
Exclusion criteria included previous myocardial infarction,
unstable angina, cardiac surgery, uncontrolled hypertension,
heart failure and renal impairment. Patients gave written
consent to participate in this study, which was approved by the
Wolverhampton District Local Research Ethics Committee.
Patients were instructed to omit treatment on the day of
the ETT. A resting blood sample was collected into gel tubes
(Sarstead Monovet 4.7 ml, Z GEL, Sarstedt, Numbrecht,
Germany), after which patients underwent an exercise test
according to a standard Bruce protocol.13 Another blood
sample was collected 15 min after exercise. Samples were
separated within 60 min and serum frozen at 280 C˚ until
assayed for NT-proBNP.
Analytical methods
NT-proBNP was measured by electrochemiluminescence
immunoassay (Elecys proBNP, Roche Diagnostics GmbH,
Mannheim, Germany) on the Roche Modular Analytics E170
immunoassay analyser. The assay has a detection limit of
5 ng/l. The intra-assay and interassay coefficients of variation
for the NT-proBNP assay are 0.9% and 5.8%, respectively.
Statistical analysis
Raw data were non-parametric; however, data were normally
distributed after logarithmic transformation. The importance
of within-group and between-group continuous logarithmic
variables was, therefore, assessed by paired t test and
unpaired t test with Welch correction, respectively.
Dichotomous variables were assessed by Fisher’s exact test.
Statistical analyses were carried out using GraphPad Instat
V.3.00 for Windows 95. Results are expressed in their
pretransformed form as mean (SD).
RESULTS
We studied 14 patients with a positive ETT and 45 patients
with a negative ETT, who served as controls. Those with a
positive ETT developed chest pain during the ETT. Table 1
shows the clinical characteristics and serum NT-proBNP
results of both groups.
In summary, although matched for age, there were more
women in the ETT-negative group. Serum NT-proBNP
concentrations before and after exercise were higher
(p,0.05) in patients with positive ETT than patients with
negative ETT. After exercise, serum NT-proBNP concentra-
tions increased (p,0.001) in both groups, but the incre-
mental increase in serum NT-proBNP concentrations were
similar in both groups.
DISCUSSION
The higher baseline and post-exercise serum NT-proBNP
concentrations in patients with positive ETT than in controls
confirms increased BNP secretion in patients with CHD.1–4 In
this study, however, exercise-induced NT-proBNP secretion
was similar in patients with positive ETT and in patients with
negative ETT.
Abbreviations: BNP, B-type natriuretic peptide; CHD, Coronary heart
disease; ETT, electrocardiogram test; NT-proBNP, N-terminal proBNP
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Our study is in agreement with that reporting higher BNP
concentrations but similar incremental BNP concentrations
in patients with myocardial ischaemia compared with
controls,11 but differs from that reporting similar NT-
proBNP concentrations in patients with and without electro-
cardiographic myocardial ischaemia,12 and also differs from
those reporting increased incremental BNP responses in
those with myocardial ischaemia compared with controls.4–10
The results in our study are partly different from those
reported in the only other comparable study.12 Weber et al12,
similarly reported no difference in incremental serum NT-
proBNP concentrations between patients with and without
electrographic myocardial ischaemia, but unlike us they also
reported similar baseline and post-exercise NT-proBNP
concentrations in both study groups.
The differences in these studies could be because of
different study groups, different durations and intensities
of exercise, different techniques for diagnosing myocardial
ischaemia, different analytical techniques and type-1 and
type-2 statistical errors.
Serum NT-proBNP may be affected by age, sex and heart
rate.14 In our study, groups were matched for age and heart
rate, but 21% of patients with a positive ETT were women
compared with 36% in the control group. The higher NT-
proBNP in those with symptomatic myocardial ischaemia is
not explained by sex, as NT-proBNP is higher in women than
men.14 In this study, compared with controls, patients with a
positive ETT had reduced exercise capacity limited by
symptomatic exertion-induced myocardial ischaemia;
although not practical it is, however, possible that if patients
with a positive ETT had exercised for the same duration and
intensity as controls, there may have been a significant
between-group difference in incremental NT-proBNP results.
In summary, we confirm that patients with symptomatic
CHD have increased serum NT-proBNP concentrations. We
found no evidence to support the notion that exaggerated
exercise-induced BNP excretion is associated with reversible
exertion-induced electrocardiographic myocardial ischaemia.
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Table 1 Demographics of patients with and without myocardial ischaemia and their serum N-terminal proB-type natriuretic
peptide concentrations during an exercise echocardiograph test
Positive exercise ECG Negative exercise ECG p Value
Number 14 45
Sex, M/F 11/3 16/29 0.030
Age (years) 60.9 (11.8) 57.2 (13.8) 0.340
Systolic BP (mm Hg) 145.9 (14.4) 137.0 (19.8) 0.106
Diastolic BP (mm Hg) 84.1 (12.7) 83.9 (10.6) 0.997
Resting heart rate (beats/min) 75.5 (12.3) 75.4 (11.6) 0.999
Maximum heart rate (beats/min) 141.6 (16.9) 149.1 (22.7) 0.266
Maximum metabolic equivalents 5.97 (0.65) 9.17 (3.30) 0.002
Time exercised (min) 4.1 (2.85) 9.1 (3.2) 0.004
Pre-exercise NT-proBNP (ng/l) 71.4 (41.2) 54.0 (61.2) 0.013
Post-exercise NT-proBNP (ng/l) 76.8 (44.0)* 60.1 (69.0)* 0.020
Increase in NT-proBNP (ng/l) 4.7 (4.2) 6.2 (8.6) 0.619
BP, blood pressure; ECG, electrocardiogram; F, female; M, male; NT-proBNP, N-terminal proB-Type natriuretic peptide.
*p,0.001 compared with pre-exercise.
Results are raw pretransformed data expressed as mean (SD).
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